COLL250516P35000
- 0.00
- 0.000.00%
Collegium Pharmaceutical Newsroom
Collegium to Report First Quarter 2025 Financial Results on May 8, 2025
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Collegium Pharmaceutical Down Nearly 7%, on Track for Lowest Close Since November 2023 -- Data Talk
Needham Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $46
These 4 Measures Indicate That Collegium Pharmaceutical (NASDAQ:COLL) Is Using Debt Extensively
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
Insider Sale: EVP & Chief Financial Officer of $COLL Sells 6,396 Shares
Forecasting The Future: 4 Analyst Projections For Collegium Pharmaceutical
Express News | HC Wainwright & Co. Reiterates Buy on Collegium Pharmaceutical, Maintains $50 Price Target
Collegium Pharmaceutical Analyst Ratings
Collegium Pharmaceutical: Undervalued Stock With Strong Growth Potential and Low Risk
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
New York Manufacturing Hits Low, Inflation Fears Rise
Collegium Pharmaceutical, Inc. Announces New Chairman and Executive Leadership Appointments Amid Board Changes
Express News | Collegium Pharmaceutical Inc - Founder Michael Heffernan and Board Member Gwen Melincoff to Retire
Express News | Collegium Pharmaceutical Inc - Gino Santini Appointed as Chairman of the Board
Express News | Collegium Announces Updates to Its Board of Directors and Executive Leadership Team
Press Release: Collegium Announces Updates to Its Board of Directors and Executive Leadership Team
Collegium Pharmaceutical Insider Sold Shares Worth $313,413, According to a Recent SEC Filing